Defen Lu
Impact in
- Immunology top 5%
- interferon and immune responses
- Immune Response and Inflammation
- Endocrinology top 5%
- Vibrio bacteria research studies
Papers in ⓘ
-
- Ubiquitin and proteasome pathways 4
- RNA modifications and cancer 2
-
- Viral Infections and Vectors 5
- Co-authors
- Guijun Shang (14 shared papers)Xuewu Zhang (5 shared papers)Xiao‐chen Bai (3 shared papers)Lichuan Gu (6 shared papers)Deyu Zhu (3 shared papers)Sujuan Xu (6 shared papers)Qian Yu (4 shared papers)Yanyu Zhao (4 shared papers)
- Journals
- Journal of Biological Chemistry (3 papers)Nature Communications (2 papers)Virus Research (1 paper)Molecular Microbiology (1 paper)Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease (1 paper)
- Partner nations
- ChinaUnited StatesPakistan
In The Last Decade
Defen Lu
20 papers receiving 826 citations
Peers
Comparison fields: 5 of 72
- Immunology 456
- Endocrinology 89
- Infectious Diseases 235
- Molecular Medicine 44
- Molecular Biology 518
Countries citing papers authored by Defen Lu
This map shows the geographic impact of Defen Lu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Defen Lu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Defen Lu more than expected).
Fields of papers citing papers by Defen Lu
This network shows the impact of papers produced by Defen Lu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Defen Lu. The network helps show where Defen Lu may publish in the future.
Co-authors
The 25 scholars most cited alongside Defen Lu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 22 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2012 | 189 | |
| 2 | 2022 | 116 | |
| 3 | 2009 | 102 | |
| 4 | 2014 | 56 | |
| 5 | 2011 | 45 | |
| 6 | 2024 | 41 | |
| 7 | 2017 | 39 | |
| 8 | 2012 | 37 | |
| 9 | 2021 | 35 | |
| 10 | 2014 | 31 | |
| 11 | 2014 | 25 | |
| 12 | 2019 | 25 | |
| 13 | 2022 | 24 | |
| 14 | 2013 | 20 | |
| 15 | 2012 | 20 | |
| 16 | 2020 | 11 | |
| 17 | 2023 | 7 | |
| 18 | 2025 | 5 | |
| 19 | 2013 | 4 | |
| 20 | 2023 | 2 |
About Defen Lu
Defen Lu is a scholar working on Molecular Biology, Infectious Diseases, Immunology, Endocrinology and Molecular Medicine, having authored 22 papers that have together received 834 indexed citations. Recurring topics across this work include interferon and immune responses (7 papers), Vibrio bacteria research studies (5 papers), Viral Infections and Vectors (5 papers), Escherichia coli research studies (4 papers), Antibiotic Resistance in Bacteria (4 papers), Ubiquitin and proteasome pathways (4 papers), Immune Response and Inflammation (2 papers) and RNA modifications and cancer (2 papers). The work is most often cited by research in Immunology (456 citations), Endocrinology (89 citations), Infectious Diseases (235 citations), Molecular Medicine (44 citations) and Molecular Biology (518 citations). Defen Lu has collaborated with scholars based in China, United States and Pakistan. Frequent co-authors include Guijun Shang, Xuewu Zhang, Xiao‐chen Bai, Lichuan Gu, Deyu Zhu, Sujuan Xu, Qian Yu, Yanyu Zhao, Chunyuan Zhu and Jie Li. Their work appears in journals such as Journal of Biological Chemistry, Nature Communications, Virus Research, Molecular Microbiology and Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.